Tag: vaccine
Vaxxas to develop first room-temperature stable RSV vaccine with NIH license
Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV).
Researchers unlock key to more effective vaccines
Researchers from the Centenary Institute and the University of Sydney have made a breakthrough in vaccine science by uncovering new insights into delta inulin, a crucial vaccine component.
NSW manufactures first-ever livestock vaccine in-house
The NSW Government announced it is investing in and prioritising the biosecurity of NSW, with a cutting-edge emergency animal disease vaccine reaching a major milestone.
La Trobe University to house BioNTech’s new mRNA manufacturing facility
La Trobe University’s Melbourne campus will soon become home to a new BioNTech facility that will manufacture new investigational mRNA therapies for serious diseases like cancer.
University of Adelaide projects win grants to foster research partnerships
Researchers from the University of Adelaide have received federal grants that will support two projects that will help develop a vaccine to protect poultry against salmonella and identify important plant compounds.
National team of experts developing technology to boost Australia’s vaccine manufacturing capability
A team of scientific experts are developing a biopolymer particle-based platform technology that will bring Australia a step closer towards establishing a sovereign capability to rapidly manufacture vaccines against emerging infectious diseases.
Vaxxas’ new needle-free vaccine manufacturing plant opens in Queensland
Biotechnology company Vaxxas has completed work on its new needle-free vaccine technology manufacturing facility in Northshore Hamilton.
Vaxxas unveils positive clinical trial results for needle-free COVID-19 vaccine
Australia biotechnology company Vaxxas said it achieved positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate.
CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion
CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing.
WEHI-led research on anti-cancer vaccine receives $900,000 MRFF funding
Walter and Eliza Hall of Medical Research (WEHI) has received a $900,000 grant from the Medical Research Future Fund for a research study that could produce a vaccine for patients with hard-to-treat cancers.
Featured Article
Building resilience as manufacturing requirements become more complex
The industrial machinery and heavy equipment manufacturing sector is critical not only for its direct outputs, machines, and equipment that pave the way for construction, agriculture and manufacturing but also for its crucial role in economic development and innovation.
